Limon-de la Rosa Nathaly, Cervantes-Alvarez Eduardo, Méndez-Guerrero Osvely, Gutierrez-Gallardo Miguel A, Kershenobich David, Navarro-Alvarez Nalu
Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.
PECEM, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04360, Mexico.
Biology (Basel). 2022 Apr 11;11(4):580. doi: 10.3390/biology11040580.
Independent predictors of mortality for COVID-19 patients have been identified upon hospital admission; however, how they behave after hospitalization remains unknown. The aim of this study is to identify clinical and laboratory parameters from admission to discharge or death that distinguish survivors and non-survivors of COVID-19, including those with independent ability to predict mortality. In a cohort of 266 adult patients, clinical and laboratory data were analyzed from admission and throughout hospital stay until discharge or death. Upon admission, non-survivors had significantly increased C reactive protein (CRP), neutrophil count, neutrophil to lymphocyte ratio (NLR) (p < 0.0001, each), ferritin (p < 0.001), and AST (aspartate transaminase) (p = 0.009) compared to survivors. During the hospital stay, deceased patients maintained elevated CRP (21.7 mg/dL [admission] vs. 19.3 [hospitalization], p = 0.060), ferritin, neutrophil count and NLR. Conversely, survivors showed significant reductions in CRP (15.8 mg/dL [admission] vs. 9.3 [hospitalization], p < 0.0001], ferritin, neutrophil count and NLR during hospital stay. Upon admission, elevated CRP, ferritin, and diabetes were independent predictors of mortality, as were persistently high CRP, neutrophilia, and the requirement of invasive mechanical ventilation during hospital stay. Inflammatory and clinical parameters distinguishing survivors from non-survivors upon admission changed significantly during hospital stay. These markers warrant close evaluation to monitor and predict patients’ outcome once hospitalized.
COVID-19患者入院时的死亡独立预测因素已被确定;然而,它们在住院后的表现仍不清楚。本研究的目的是确定从入院到出院或死亡期间的临床和实验室参数,以区分COVID-19的幸存者和非幸存者,包括那些具有独立预测死亡率能力的参数。在一组266例成年患者中,分析了入院时及整个住院期间直至出院或死亡的临床和实验室数据。入院时,与幸存者相比,非幸存者的C反应蛋白(CRP)、中性粒细胞计数、中性粒细胞与淋巴细胞比值(NLR)(均p<0.0001)、铁蛋白(p<0.001)和谷草转氨酶(AST)(p=0.009)显著升高。在住院期间,死亡患者的CRP(入院时21.7mg/dL vs.住院时19.3mg/dL,p=0.060)、铁蛋白、中性粒细胞计数和NLR持续升高。相反,幸存者在住院期间CRP(入院时15.8mg/dL vs.住院时9.3mg/dL,p<0.0001)、铁蛋白、中性粒细胞计数和NLR显著降低。入院时,CRP升高、铁蛋白升高和糖尿病是死亡的独立预测因素,住院期间持续高CRP、中性粒细胞增多和有创机械通气需求也是如此。入院时区分幸存者和非幸存者的炎症和临床参数在住院期间发生了显著变化。这些标志物值得密切评估,以便在患者住院后监测和预测其预后。